SUMMARY Using a method for measuring changes in transmural potential difference across the human jejunum in vivo, the operational kinetic parameters of 'Apparent Km' and PD max for the active electrogenic component of glucose absorption were estimated in a group of healthy volunteers and in patients with coeliac disease. Both the 'Apparent Km' (17 2 mM; mean SEM) and the PD max (8.6 ± 0 7 mV) in nine patients with untreated coeliac disease were significantly lower (p < 0 005) than in the control group ('Apparent Km' = 74 ± 5 mM; PD max 12-8 ± 0-9 mV, n = 20). Treatment of five coeliac patients by gluten withdrawal for less than three months increased significantly the values of both the 'Apparent Km' (35 ± 6 mM) and the PD max (1li4 ± 1-2 mV). Treatment of five patients for more than six months caused a further increase in the values of both kinetic parameters ('Apparent Km' = 108 ± 13 mM; PD max = 15-6 ± 2-7 mV) to levels which exceeded those in healthy subjects. The possible interpretations of the differences in the kinetic characteristics of electrogenic glucose transport between coeliac patients and healthy subjects are discussed.
In a previous study we described a technique for characterising the active electrogenic component of glucose absorption in man (Read et al., 1974) . We have now applied this method to investigate changes in electrogenic glucose absorption in patients with active and treated coeliac disease.
Methods

SUBJECTS
Tests of electrogenic glucose absorption were carried out on a group of 10 male and 10 female young healthy volunteers and on patients with coeliac disease, who were diagnosed on the criteria of clinical evidence of malabsorption, the typical biopsy appearance of total or subtotal villous atrophy, and response to treatment by gluten withdrawal. In the coeliac group tests were carried out on nine patients who had received no treatment, five patients treated for less than three months, and five patients treated for more than six months. These subgroups included the patients in Table 3 who were tested on more than one occasion. All the treated patients had evidence of either clinical or histological Received for publication 23 February 1976 response to withdrawal of gluten at the time of testing.
The method for characterising electrogenic glucose absorption by measuring jejunal transmural potential differences (PDs) was identical with that previously described (Read et al., 1974) . In brief, an intestinal tube was swallowed and positioned with its tip approximately 5 cm beyond the duodenojejunal flexure. An intramuscular injection of 30 mg propantheline bromide (Pro-banthine) was then administered. This reduced the normal fluctuations in the record, which varied in amplitude up to 10 mV, to levels (less than 1 mV) sufficiently stable for the measurement of small changes in PD. The solutions shown in Table 1 were infused at a constant rate of 5 ml per minute and the resultant changes in PD between the flowing intraluminal electrode and subcutaneous reference electrode were recorded. A typical record obtained from a patient with untreated coeliac disease is shown in Fig. 1 . The infusion of solution 1, containing mannitol but no glucose, provided a baseline PD with the lumen a few millivolts positive to the subcutaneous reference site. Subsequent infusion of a series of solutions containing increasing concentrations of glucose (Table 1) (Table 3 ). In the group treated with a gluten-free diet for more than six months the 'Apparent Km' was significantly greater than that observed in healthy controls but the PD max was not significantly higher. Whether this enhanced 'Apparent Km' has a functional significance is as yet unknown. The actual dose response curve for electrogenic glucose absorption (Fig. 3) for these treated patients is not significantly different from that for normal subjects and, in general, the higher the values for 'Apparent Km' the less meaningful becomes the functional significance of differences of this parameter.
The method of characterising intestinal absorption by the determination of saturation kinetic parameters was initially borrowed from studies on enzyme substrate interactions (Fisher and Parsons, 1953; Smyth, 1971) . Its further application to electrical measurements of transfer activity came from the in vitro studies of Asano (1964) , Schultz and Zalusky (1964) , and Lyon and Crane (1966) . Debnam and Levin (1975a, b) extended its application to in vivo studies and showed that the 'Apparent Km' for the active electrogenic component of glucose absorption is the same whether calculated from measurements of hexose transfer PDs or from the chemically measured loss of glucose from the lumen. This study suggests that in vivo electrical and chemical methods can be used to characterise the same process. A controversial point conceming values of 'Apparent Km' and PD max is whether they can ever be used as indices of carrier affinity and transfer capacity respectively. If they can, it would allow inferences to be made about the effects of coeliac disease on absorption mechanisms. One possible way of investigating this appealing prospect is to see whether the changes in electrical parameters determined in our study are matched by corresponding changes in chemical parameters in man. At present we have found that it is technically impossible to design a satisfactory protocol to measure accurately glucose absorption both chemically and electrically during the same experiment. This is because the probanthine required to obtain satisfactory stability for electrical recording makes quantitative recovery of infusions containing glucose from a sitelower down the intestine extremely variable. Two previous perfusion studies have, however, measured the disappearance of glucose from the jejunal lumen of normal and coeliac subjects at several infused concentrations (Schedl and Clifton, 1961; Holdsworth and Dawson, 1965) . Both studies showed a decrease in maximal glucose absorption (Jmax) in the untreated coeliac groups compared to normal controls. The data of Holdsworth and Dawson (1965) , moreover, shows that the absorption curve in the untreated coeliac group clearly saturates at a much lower concentration of glucose than the controls and thus has a lower 'Apparent Km'. Therefore, there is a clear association in untreated coeliac disease between decreases in Jmax and PD max and also reductions in chemical and electrical 'Apparent Kms'. While such associations can never be regarded as proof of a causal relationship, it is more than tempting to suggest that the changes in the electrical data are concomitant with the changes in glucose absorption, measured chemically.
Kinetic parameters, however, whether obtained by chemical or electrical techniques are affected by a number of experimental complications. Among these is the thickness of the unstirred water layer through which glucose has to diffuse before being actively transferred by the enterocyte. This has been shown to exert a profound influence on experimental values for Km and Jmax in vitro (Winne, 1973; Wilson and Dietschy, 1974; Dugas et al., 1975) . By extrapolation of these data, it is possible that the reduction in the operational electrogenic parameters in coeliac disease (Km, PD max) could arise from attenuation of the unstirred layer.
The decreased PD max observed in untreated coeliac disease may be due not only to changes in the ion-linked active transfer mechanisms, but also to alteration in intestinal mucosal resistance. No measurements of this resistance have been made in coeliac disease even in vitro and it is unlikely that any simple technique could be applied to assess it in vivo. However, studies have shown that in vivo the jejunal mucosa in this condition exhibits a greater resistance to the diffusional movements of several solutes (Fordtran et al., 1967) . While there is no proven direct correlation between diffusional and electrical resistances, the data do not support the possibility that the observed low PD max in coeliac disease may be due to low mucosal resistance.
Other factors affecting the values of 'Apparent Km' and PD max are technical, such as the possible reduction of the effective glucose concentration by pooling of the serially infused solutions. Because the electrogenic absorption curve appears to exhibit saturation kinetics, the PDs obtained at low glucose concentrations are liable to be lowered more by pooling than those obtained at the higher concentrations, near saturation level. Thus conditions in which there is increased pooling alter the shape of the absorption curve and lead to higher experimental values for Km and PD max. All the available evidence indicates that there is greater possibility of pooling in coeliac disease compared with normal subjects, in that there is less absorption of solute and water (Schedl and Clifton, 1961; Holdsworth and Dawson, 1965) , and more secretion (Fordtran et al., 1967; Schmid et al., 1969; Russell et al., 1972) while the jejunal tone and motility are reduced (Ingelfinger and Moss, 1943; Ritchie and Salem, 1965) . The fact that the 'Apparent Km' and PD max are actually lower in untreated coeliac disease strongly suggests that pooling does not account for the observed differences between this group and the controls.
In conclusion, despite the uncertainties in interpretation of kinetic parameters for electrogenic glucose transfer, the changes found in coeliac disease are qualitatively similar to those found by perfusion techniques in which glucose absorption was measured chemically. The total perfusion time for such chemical kinetic studies is much longer, being a minimum of five hours as compared with 90 minutes for the electrical test. The real meaning of the kinetic parameters obtained by either method is still subject to debate, but data obtained previously in the rat suggests that the electrical method might even give more accurate information about active glucose transport than the chemical method which does not discriminate between active and passive glucose absorption. The narrow single lumen tube used for the electrical method involves no more discomfort than that used for jejunal biopsy, which can indeed be carried out at the end of the test. It thus compares favourably with the four lumen tube used currently for the chemical method. Clearly, a considerable amount of work is required before the electrical test could be advocated for routine clinical usage but at present it provides a useful research tool for the further exploration of absorptive pathophysiology. 
